136 related articles for article (PubMed ID: 24082086)
21. Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
Li Z; Luo RT; Mi S; Sun M; Chen P; Bao J; Neilly MB; Jayathilaka N; Johnson DS; Wang L; Lavau C; Zhang Y; Tseng C; Zhang X; Wang J; Yu J; Yang H; Wang SM; Rowley JD; Chen J; Thirman MJ
Cancer Res; 2009 Feb; 69(3):1109-16. PubMed ID: 19155294
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.
Metcalf D; Dakic A; Mifsud S; Di Rago L; Wu L; Nutt S
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1486-91. PubMed ID: 16432184
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.
Bernstein ID; Andrews RG; Zsebo KM
Blood; 1991 Jun; 77(11):2316-21. PubMed ID: 1710148
[TBL] [Abstract][Full Text] [Related]
24. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
Jamalpour M; Bergquist E; Welsh M
Exp Cell Res; 2020 Dec; 397(2):112368. PubMed ID: 33220260
[TBL] [Abstract][Full Text] [Related]
25. Induction of dependence on hematopoietic proteins for viability and receptor upregulation in differentiating myeloid leukemic cells.
Lotem J; Sachs L
Blood; 1989 Aug; 74(2):579-85. PubMed ID: 2546628
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities.
Horton SJ; Walf-Vorderwülbecke V; Chatters SJ; Sebire NJ; de Boer J; Williams O
Blood; 2009 May; 113(20):4922-9. PubMed ID: 19029444
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5.
Touw I; Donath J; Pouwels K; van Buitenen C; Schipper P; Santini V; Hagemeijer A; Löwenberg B; Delwel R
Leukemia; 1991 Aug; 5(8):687-92. PubMed ID: 1715959
[TBL] [Abstract][Full Text] [Related]
28. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
29. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells.
Murohashi I; Yoshida K; Kishimoto K; Takahashi T; Wakao D; Jinnai I; Yagasaki F; Kawai N; Suzuki T; Matsuda A; Hirashima K; Bessho M
J Interferon Cytokine Res; 2002 Mar; 22(3):335-41. PubMed ID: 12034041
[TBL] [Abstract][Full Text] [Related]
30. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
[TBL] [Abstract][Full Text] [Related]
31. Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor beta 1 in normal and leukemic myeloid cells.
Lotem J; Sachs L
Blood; 1990 Oct; 76(7):1315-22. PubMed ID: 2207308
[TBL] [Abstract][Full Text] [Related]
32. Enhanced proliferative activity of PIXY-321, the granulocyte-macrophage colony-stimulating factor and interleukin-3 fusion protein.
Drexler HG; Meyer C
Leuk Lymphoma; 1998 Mar; 29(1-2):119-28. PubMed ID: 9638981
[TBL] [Abstract][Full Text] [Related]
33. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O
Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462
[TBL] [Abstract][Full Text] [Related]
34. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool.
Carlesso N; Pregno P; Bresso P; Gallo E; Pileri A; Zsebo KM; Ferrero D
Leukemia; 1992 Jul; 6(7):642-8. PubMed ID: 1378162
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells.
Bhalla K; Tang C; Ibrado AM; Grant S; Tourkina E; Holladay C; Hughes M; Mahoney ME; Huang Y
Blood; 1992 Dec; 80(11):2883-90. PubMed ID: 1450413
[TBL] [Abstract][Full Text] [Related]
36. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
Frankel AE; Lilly M; Kreitman R; Hogge D; Beran M; Freedman MH; Emanuel PD; McLain C; Hall P; Tagge E; Berger M; Eaves C
Blood; 1998 Dec; 92(11):4279-86. PubMed ID: 9834234
[TBL] [Abstract][Full Text] [Related]
37. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
38. Learning from mouse models of MLL fusion gene-driven acute leukemia.
Schwaller J
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
[TBL] [Abstract][Full Text] [Related]
39. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
[TBL] [Abstract][Full Text] [Related]
40. Leukemic transformation of primary myelofibrosis: immunophenotype, genotype and growth characteristics of blast cells.
Kimura A; Kawaishi K; Nakata Y; Hyodo H; Kuramoto A; Satow Y
Leuk Lymphoma; 1995 Nov; 19(5-6):493-8. PubMed ID: 8590852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
